However, treatment of HCC tissues with the combination therapy led to higher expression of ZNF225; the combination therapy also led to downregulation of LC3B, as well as upregulation of p62, suggesting autophagy reduction. The gene discussed is MAP1LC3B; the disease is hepatocellular carcinoma.